李宣佑周明勇蘇茂昌Mao-Chang醫學研究所2026-10-289999-12-312008https://handle.ncl.edu.tw/11296/y9t396https://scholars.csmu.edu.tw/handle/123456789/35607約有1/1000嬰兒在出生時或在小孩早期(即語言學習前時期prelingual period)罹患重度聽損(severe or profound hearing loss),在已開發國家約有60%個案是遺傳因素。到目前為止已知有59個基因發生突變而造成遺傳性聽損,各基因的致病機制不盡相同,非常複雜。本論文主要探討耳蝸內影響離子濃度恆定性的MYO7A和TMIE基因變異與非症候群聽損之間的關係。藉由分析聽力正常和聽損的人來建立一個台灣地區MYO7A和TMIE基因變異之資料庫,以瞭解MYO7A和TMIE基因突變在非症候群聽損所佔的比例,可作為聽損遺傳諮詢參考;另外藉由在老鼠耳蝸內TMIE基因表現的探討來了解該基因在聽力形成中所扮演的角色。本研究的結果,在MYO7A基因篩檢方面,我們在 MYO7A基因exon 7、exon 11、exon 22和exon 28等4個exons篩檢中一共發現6個變異(variants) 。在這6個變異中,只有在exon 22片段的c.IVS22+58G>A變異被同時發現在正常人和聽損患者中,從統計分析中我們建議c.IVS22+58G>A這個變異可能是造成非症候群聽損一個保護因子,如果帶有這個變異可能會降低其罹患此病的機率。另外5個變異包括三個是missense變異(Arg206Cys、Arg206His 和 Thr381Met)、一個是silent變異(c.639C>T)和一個intron變異(c.IVS6-17C>T )都只在聽損病人中發現。在TMIE基因篩檢的分析中我們一共發現7個新的變異,其中有5個變異同時被發現在正常人和聽損患者中,從統計分析中這5個變異在病人和正常人間所佔的比例並無明顯區別。另外有2個變異只在聽損病人中發現,包括一個是missense變異(Arg86Gln)和一個在promoter區的變異(g.-219A>T)。同時本研究我們利用免疫組織化學染色、雷射細胞擷取和RT-PCR等方法來探討老鼠耳蝸內Tmie的分布情形,結果發現此種蛋白質或mRNA可表現在老鼠的螺旋紋(spiral limbus)、螺旋韌帶(spiral ligaments)、柯蒂氏器(organ of Corti) 和血管紋(stria vascularis)。綜合以上研究結果,我們已建立台灣地區非症候群聽損病人的MYO7A基因exon 7、exon 11、exon 22和exon 28等4個exons及TMIE基因變異的資料庫,同時也探討了TMIE在耳蝸內的表現位置,這些完整資料的建立,可以讓我們對於MYO7A和TMIE基因在台灣地區非症候群遺傳性聽損的成因有進一步的瞭解。In the developed countries, the incidence of congenital hearing loss is estimated at 1 in 1000 births, of which approximately 60% cases are attributed to genetic factors. To date, 59 auditory genes have been identified, some of which are those involved in K+ recycling and maintenance. The importance of K+ recycling and maintenance is underscored by the fact that mutations in each of MYO7A or TMIE, leads to hearing loss in human. However, in Taiwan, the data of MYO7A and TMIE genes are still insufficient; therefore, further research is worthy to conduct. The overall goal of this thesis is to establish the genetic basis for the screening, diagnosis, and pathogenesis studies of MYO7A and TMIE of non-syndromic hearing loss in Taiwan. In this study, we aim to determine the variants sited of the MYO7A and TMIE gene by using comparative genetic analysis between genomic DNA from normal individuals and hearing-impaired patients; and to understand expression of Tmie in cochlea of rat. The analysis revealed 6 variants in 3 out of 4 screened exons of the MYO7A gene (exon 7, 11, and 22). Three missense variants were found only in patients with hearing loss and were heterozygous, including Arg206Cys, Arg206His and Thr381Met. A variant, c.IVS22+58G>A, was found in intron 22 of the MYO7A gene from both patients and control group. Allele frequencies of c.IVS22+58G>A was shown to be significant between the two groups using chi-square (χ2) test (p<0.05). Therefore, we suggested the variant c.IVS22+58G>A may be protective against hearing loss in the Taiwanese. In addition, the analysis revealed 7 novel variants in the TMIE gene. Of the 7 variants, 5 variants were found in both nonsyndromic hearing loss and normal hearing group. Both allelic and genotype frequencies of these sequence changes did not differ significantly between patients and controls (P>0.05). However, a missense variant (Arg86Gln) and one promoter variant (g.-219A>T) were found only in the patients with nonsyndromic hearing loss. Additionally, we located and determined the cellular expression of Tmie within the rat cochlea using a polyclonal anti-Tmie antibody in this thesis. The expression products of Tmie were detected in the spiral limbus, spiral ligament, organ of Corti, and stria vascularis by immunohistochemistry analysis and RT-PCR. In summary, our study provides information for understanding the importance of genetic factors in nonsyndromic hearing loss of Taiwanese. Knowledge of spatial distribution of Tmie will provide important insight into the mechanisms that lead to hearing loss due to mutations in the TMIE gene.TMIE和MYOSIN VIIA基因在台灣地區非症候群聽損之研究thesis